Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

VVUS Insider Trading

VVUS | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at VVUS provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2015-01-10 00:37 2015-01-07 NORTH TIDE CAPITAL, LLC 10% owner BUY $3.12 500,000 $1,561,350 12,500,000 +4.2%
2015-01-08 00:14 2015-01-05 NORTH TIDE CAPITAL, LLC 10% owner BUY $3.04 476,800 $1,451,188 12,000,000 +4.1%
2015-01-06 00:21 2014-12-31 NORTH TIDE CAPITAL, LLC 10% owner BUY $2.90 523,200 $1,515,501 11,523,200 +4.8%
2014-03-13 01:37 2014-03-11 Fischer Seth H.Z. Director, Officer - Chief Executive Officer BUY $6.07 3,080 $18,695 3,080 +100.0%
2013-11-13 01:08 2013-11-08 DENNER ALEXANDER J Director BUY $8.59 566,844 $4,868,453 2,573,943 +28.2%
2013-09-10 02:29 2013-09-05 MORRIS TIMOTHY E Officer - VP, Finance and CFO OPT+S $11.95 10,654 $127,283 0 0.0%
2013-09-06 23:09 2013-09-04 ASTRUE MICHAEL J Director BUY $11.96 10,000 $119,597 10,000 +100.0%
2013-07-02 01:21 2013-06-27 BIRO JON C 10% owner, Other BUY $12.85 2,000 $25,699 4,000 +100.0%
2013-05-30 20:54 2013-05-29 MARIO ERNEST Director BUY $14.68 15,000 $220,206 81,125 +22.7%
2012-08-22 02:03 2012-08-20 MARIO ERNEST Director BUY $20.75 5,000 $103,750 45,000 +12.5%
2012-08-22 02:00 2012-08-20 CASAMENTO CHARLES J Director OPT+S $20.63 8,000 $165,060 66,000 0.0%
2012-08-16 02:53 2012-08-14 SHORTLIFFE LINDA M DAIRIKI Director OPT+S $22.72 18,000 $409,000 5,000 0.0%
2012-08-16 02:54 2012-08-14 LOGAN MARK B Director OPT+S $23.13 49,816 $1,152,169 53,000 0.0%
2012-08-15 01:47 2012-08-10 SHORTLIFFE LINDA M DAIRIKI Director OPT+S $21.72 45,000 $977,499 5,000 0.0%
2012-08-15 01:52 2012-08-13 LOGAN MARK B Director OPT+S $21.81 18,184 $396,580 53,000 0.0%
2012-08-14 01:00 2012-08-09 MARIO ERNEST Director BUY $21.75 20,000 $434,900 40,000 +100.0%
2012-07-21 02:21 2012-07-18 Slebir John L Officer - VP, General Counsel OPT+S $30.36 10,000 $303,600 4,126 0.0%
2012-07-21 02:15 2012-07-18 Day Wesley Officer - VP, Clinical Research SELL $30.36 16,800 $510,048 0 -100.0%
2012-07-21 02:10 2012-07-18 MARSH GUY P Officer - VP, Operations and General Mgr OPT+S $30.36 36,191 $1,098,759 2,074 0.0%
2012-07-21 02:17 2012-07-18 TAM PETER Y Director, Officer - President OPT+S $30.95 25,000 $773,750 37,629 0.0%
2012-07-21 02:07 2012-07-18 MILLER MICHAEL PATRICK Officer - Chief Commercial Officer OPT+S $30.36 25,000 $759,000 7,943 0.0%
2012-07-21 02:14 2012-07-18 MORRIS TIMOTHY E Officer - VP, Finance and CFO OPT+S $30.36 25,000 $759,000 0 0.0%
2012-07-21 02:12 2012-07-18 WILSON LELAND F Director, Officer - CEO OPT+S $30.36 100,000 $3,036,000 119,112 0.0%
2012-07-03 04:49 2012-06-27 WILSON LELAND F Director, Officer - CEO OPT+S $28.00 50,000 $1,400,000 119,112 0.0%
2012-06-30 00:01 2012-06-27 MILLER MICHAEL PATRICK Officer - Chief Commercial Officer OPT+S $28.08 25,000 $701,900 7,943 0.0%
2012-06-21 02:29 2012-06-19 TAM PETER Y Director, Officer - President OPT+S $27.25 20,000 $545,000 37,629 0.0%
2012-06-20 01:42 2012-06-18 TAM PETER Y Director, Officer - President OPT+S $26.45 20,000 $529,000 37,629 0.0%
2012-06-19 04:25 2012-06-14 TAM PETER Y Director, Officer - President SELL $25.25 60,000 $1,515,000 37,629 -61.5%
2012-06-19 04:24 2012-06-14 TAM PETER Y Director, Officer - President OPT+S $25.28 236,250 $5,973,534 97,629 0.0%
2012-06-15 00:11 2012-06-12 MILLER MICHAEL PATRICK Officer - Chief Commercial Officer OPT+S $25.00 25,000 $625,000 7,943 0.0%
2012-06-13 20:11 2012-06-11 WILSON LELAND F Director, Officer - CEO OPT+S $25.18 50,000 $1,259,000 119,112 0.0%
2012-03-20 21:44 2012-03-16 LOGAN MARK B Director OPT+S $20.32 14,000 $284,453 48,000 0.0%
2012-03-20 01:28 2012-03-15 MARSH GUY P Officer - VP, Operations & General Mgr. SELL $20.31 6,605 $134,148 1,106 -85.7%
2012-03-13 23:48 2012-03-12 CASAMENTO CHARLES J Director OPT+S $20.14 37,000 $745,217 61,000 0.0%
2012-03-13 00:24 2012-03-09 Perry Lee Officer - VP & Chief Accounting Officer OPT+S $20.96 87,623 $1,836,210 0 0.0%
2012-03-13 00:24 2012-03-08 SHORTLIFFE LINDA M DAIRIKI Director OPT+S $21.50 52,000 $1,118,000 0 0.0%
2012-02-28 22:53 2012-02-27 MARSH GUY P Officer - VP, Operations and General Mgr OPT+S $22.93 47,078 $1,079,499 7,711 0.0%
2012-02-28 22:53 2012-02-27 WILSON LELAND F Director, Officer - CEO OPT+S $25.00 50,000 $1,250,000 118,271 0.0%
2012-02-28 05:51 2012-02-23 MORRIS TIMOTHY E Officer - SVP, Finance and CFO OPT+S $21.26 329,358 $7,002,415 0 0.0%
2012-02-25 04:30 2012-02-23 Perry Lee Officer - VP & Chief Accounting Officer OPT+S $20.69 171,832 $3,555,204 0 0.0%
2012-02-25 04:33 2012-02-23 Day Wesley Officer - VP, Clinical Development OPT+S $20.69 79,958 $1,654,331 16,800 0.0%
2012-02-25 04:36 2012-02-23 MARSH GUY P Officer - VP, Operations & General Mgr. OPT+S $20.70 86,777 $1,796,284 7,711 0.0%
2012-02-25 04:38 2012-02-23 WILSON LELAND F Director, Officer - Chief Executive Officer OPT+S $20.69 150,000 $3,103,500 118,271 0.0%
2012-01-13 19:33 2012-01-11 TAM PETER Y Director, Officer - President SELL $12.00 27,014 $324,168 96,221 -21.9%
2012-01-11 22:37 2012-01-09 Perry Lee Officer - VP & Chief Accounting Officer OPT+S $11.75 39,700 $466,475 0 0.0%
2012-01-11 22:34 2012-01-09 Day Wesley Officer - VP, Clinical Development OPT+S $11.50 30,000 $345,000 16,800 0.0%
2012-01-12 01:12 2012-01-10 TAM PETER Y Director, Officer - President SELL $12.00 12,386 $148,632 123,235 -9.1%
2011-11-16 03:26 2011-11-11 Day Wesley Officer - VP, Clinical Development OPT+S $9.87 23,442 $231,349 16,800 0.0%
2011-01-08 02:22 2010-12-17 Day Wesley Officer - VP, Clinical Development SELL $9.54 70,600 $673,446 16,800 -80.8%
2010-12-21 01:37 2010-12-16 TAM PETER Y Director, Officer - President OPT+S $9.28 10,000 $92,807 126,775 0.0%
SHOW ENTRIES

How to Interpret $VVUS Trades

Not every insider transaction in VVUS is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $VVUS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for VVUS

Insider activity data for VVUS is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $VVUS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.